Company Comparison
Nurix Therapeutics vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Nurix Therapeutics | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | — |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
Nurix Therapeutics
A clinical-stage biopharmaceutical company developing precision medicines using targeted protein degradation technology for cancer and inflammatory diseases.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Sector Overlap
Both Nurix Therapeutics and 10x Genomics operate in Biotech.
Browse all Biotech companies →